CLINICAL OBSERVATION ON TREATMENT OF A PATIENT WITH ASCENDING COLON CANCER OCCURRING DURING THE LONG-TERM USE OF IMMUNOSUPPRESSANTS AFTER CADAVERIC KIDNEY ALLOTRANSPLANTATION FOR DECOMPENSATED RENAL FAILURE
https://doi.org/10.17650/2220-3478-2013-0-1-58-60
Abstract
A case report of a patient with advanced colorectal cancer complicated by 18-year immunosuppressive drug therapy after kidney transplantation is presented. Long-term use of immunosuppressive drugs may complicate postoperative period, but must not be a contradiction to extensive abdominal and pelvic surgery.
About the Authors
O. A. Vlasov
N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
Yu. M. Timofeyev
N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
References
1. Давыдов М.И., Аксель Е.М. Злокачественные новообразования в России и странах СНГ в 2009 г. Вестник РОНЦ им. Н.Н. Блохина РАМН. М., 2011;22;3(85) (прил. 1).
2. Andres A. Cancer incidence after immunosupresive treatment following kidney transplantation. Crit Rev Oncol Hematol 2005 Oct;56(1):71–85.
3. Engels E.A., Pfeiffer R.M., Fraumeni J.F. et al. Spectrum of cancer risk among US solid organ transplant recipients. JAMA 2011 Nov 2;306(17):1891–901.
4. Van Leeuwen M.T., Webster A.C., McCredie M.R., et al. Effect of reduced immunossupression after kidney transplant failure on risk of cancer: population based retrospective cohort study. BMJ 2010;340:c570.
5. Gallagher M.P., Kelly P.J., Jardine M. et al. Long-term cancer risk ofimmunosuppressive regimens after kidney transplantation. J Am Soc Nephrol 2010 May;21(5):852–8.
6. Ross K. For organ transplant recipients, cancer threatens long-term survival. J Natl Cancer Inst 2007;99(6):421–2.
Review
Views:
716
Email this article 